To read the scientific committee member's biosketch, click on their name.

To read the speaker's biosketch, click on their name.

Abstracts are uploaded upon receipt.

Day 1 – Tuesday, 29th of September

Use of Bovine Serum and NGS testing of drug products: mitigation of inert viral sequences while controlling the risk of viral contamination
Marc Eloit, PathoQuest
Abstract

Day 2 – Wednesday, 30th of September

Review of European Pharmacopeia requirements for the use of Bovine serum for the production of human and veterinary medicinal products
Catherine Lebrun, EDQM
Abstract

Conference e-book will be available soon

Access to meeting’s slides is given to meeting’s participants for a period of 4 weeks after the meeting.
Login and password are sent by email to participants right after the meeting.
Afterwards the slides are only accessible to IABS members, using their Member Login and Password.

The International Alliance for Biological Standardization (IABS) is an independent, non-profit scientific alliance, with headquarters in Geneva (Switzerland).

IABS was founded in 1955 in Lyon, France by a group of experts who believed that such an organization could provide a forum where data could be discussed among scientists to improve the quality and the regulation of biological products from human and animal origin. IABS has members in over 50 countries.

OFFICERS

• Dr. Olivier Espeisse, President
• Dr. Hendrik-Jan Ormel, Vice-President
• Dr. Joris Vandeputte, Past-President
• Mr. Vincent Guilmeau, Treasurer
• Dr. Carmen Jungbäck, Secretary

MISSION

The mission of the Alliance which is related to the scientific and medical advancement of Biologicals, includes :

• To host conferences and workshops, facilitate communication, and develop consensus on key contemporary issues related to biologicals among those who discover, develop, produce and regulate biological products for human and animal health
• To foster evidence-based Science as the standard for improving and ensuring the quality and the safety of biological products
• To share scientific advancements and innovative regulatory solutions through our journal “Biologicals”.

PUBLICATIONS

Reports and proceedings of IABS-EU conferences and workshops appear in its journal Biologicals, published by Elsevier.

MEMBERSHIP BENEFITS

• Affiliations with a global community of recognized experts
• Exclusive access to archived information from scientific events (library of speaker presentations, conclusions and recommendations)
• Reduced fees for a subscription to the journal Biologicals
• Voting rights for matters discussed during the Biennial IABS-EU General Assembly (Elections, Constitutional changes)

For more information on how to become a member of IABS-EU, please visit: www.iabs.org